The potential use of retrovirus vectors to transduce foreign genetic information into cells of different tissues of an animal was explored by introducing a recombinant genome carrying the Eco gpt gene into postimplantation mouse embryos. To obviate the need for preparing concentrated virus stocks, *2-2-5 cells producing the replication-defective murine sarcoma virus (MSV)-gpt virus were microinjected directly into embryos. The f2-2-5 cells were mixed with cells producing replication-competent Moloney murine leukemia virus (Mo-MuLV) to facilitate spread of the vector. A high percentage of the manipulated embryos continued to develop without disturbance and were analyzed either prior to birth or as adults for expression of both helper and Eco gpt virus. Micro-
inJection of as few as 10 Mo-MuLV-producing cells resulted in viremia of >50% of the embryos or adults, 25%-30% of which produced MSV-gpt recombinant virus in a variety of organs including thymus, spleen, lung, kidney, and brain. The fraction of vector-producing cells, however, was 3 to 5 orders of magnitude lower than that of helper-virus-producing cells. Our results demonstrate that a selectable gene can be introduced by retroviral vectors into animals and can be expressed in a wide variety of different somatic tissues.
A variety of different procedures have been developed for the introduction of foreign genes into eukaryotic cells. In most studies to date, cloned genes have been introduced into mammalian cells cultured in vitro (1, 2) , and the expression of the transduced genes has been monitored either transiently after gene transfer (3, 4) or after the generation of stable transformants (5, 6 ). An alternative approach for studies of mammalian gene expression and regulation is the introduction of genes into pluripotent cells in vivo. Such an approach provides the means for studying the expression and regulation of genes throughout a developmental pathway. To date, the introduction of genes into cells in vivo has been achieved by microinjection of cloned DNA into mouse zygotes (7) (8) (9) (10) (11) (12) (13) (14) . This procedure often results in the stable introduction of sequences into germ-line cells, yet the expression of such sequences in somatic tissues has been variable.
Retrovirus vectors have recently been used in a number of laboratories to introduce genes into cultured cells (15) (16) (17) (18) (19) (20) (21) (22) (23) . These vectors are particularly well suited for gene transfer in that they infect a variety of cell types and introduce genes at high efficiency. Studies of the interaction of Moloney murine leukemia virus (Mo-MuLV) with cells of the developing mouse embryo (24) (25) (26) (27) have suggested the possibility of using retrovirus vectors for the transfer of genes in vivo as well. Exposure of preimplantation mouse embryos to MoMuLV results in the efficient integration of proviral copies in germ-line cells (24) (25) (26) . However (28) ; infection of embryos at the preimplantation stage leads to efficient de novo methylation of proviral sequences upon chromosomal integration (29) . In contrast, retroviruses can replicate unrestricted in cells of most somatic tissue when introduced into embryos between day 8 and day 10 of gestation (27, 29) . Upon birth of the animal, however, replication is restricted to cells of lymphatic tissue (24, 27 into the placenta, essentially as described (27) . Approximately 0.2-0.5 /A of cell suspension containing =5 x 106 d2-2-5 cells per ml and 5 x 104 C12C cells per ml were injected into the embryo or into the placenta using a micropipette with a closed tip and a hole of -30 gm diameter at one side.
Radioimmunoassay. Microinjected animals were tested 4 weeks after birth for viremia by a competitive radioimmunoassay for the presence of p30 in the serum as described (32) .
Assay for Presence of Defective MSV-gpt in the Blood. Blood samples (100-200 1.d) were taken from viremic animals 5 weeks after birth and diluted 1:10 in phosphate-buffered saline/2% fetal calf serum. NIH 3T3 cells seeded the day before at a density of 0.5 x 105 cells per ml in 24-well plates in the presence of 2 ,ug of Polybrene per ml were overlaid with 0.3 ml of diluted blood samples. Twenty-four hours later, the blood cell suspension was washed off and the NIH 3T3 cells were passaged onto Petri dishes (10-cm diameter) containing Eco gpt selection medium. Plates were fixed and stained with Giemsa (Merck) 10-14 days later.
Infectious Center Assay. Organs were removed from adult mice derived from microinjected embryos between 2 and 4 months after birth or from day 19 embryos, respectively, and single cell suspensions were obtained as described (32) .
Spleen cells (1 x 107) from adult mice or 1 x 106 cells from different organs (brain, liver, kidney, lung, heart, and thymus) as well as the carcass of day 19 embryos, respectively, were seeded onto NIH 3T3 cells grown to 30%-50% confluency in medium containing 2 pug of Polybrene per ml on Petri dishes (5-cm diameter). The cells were passaged 2 days later onto Petri dishes (14-cm diameter) containing Eco gpt selective medium. Plates were fixed and stained 2 weeks later. Mycophenolic acid-resistant colonies from some plates were isolated by using cloning cylinders and grown under Eco gpt selective conditions. Supernatants of mycophenolic acid-resistant colonies were titered for Mo-MuLV helper virus by an XC plaque assay (33) as well as for MSV-gpt defective virus.
Primary Embryonal Cell Culture. Single cell suspensions from lung and part of the carcass from day 19 embryos were prepared and plated onto Petri dishes containing Dulbecco's modified Eagle's medium/20% fetal calf serum. When attachment of cells was apparent (normally 3-5 days after seeding), medium was changed. After reaching confluency, one-half of the primary culture was passaged onto Petri dishes containing Eco gpt selective medium, and -3 weeks later, mycophenolic acid-resistant colonies derived from secondary embryonal cells were transformed with simian virus 40 (SV40) to derive permanent cell lines. The other half of the primary cultures was cocultivated with NIH 3T3 cells as described above, followed by selection for mycophenolic acid resistance.
Isolation of DNA and Restriction Enzyme Analysis. High molecular weight DNA from organs of adult mice or embryos and from tissue culture cells was prepared as described (34) . The DNA was digested with Sst I (3 units per ,g of DNA) (Bethesda Research Laboratories) as described by the supplier. DNA fragments were separated on 0.8% agarose gels and transferred to nitrocellulose filters (35) . 32P-labeled nick-translated probes of pSV2-gpt were prepared and hybridized to nitrocellulose filters as described (36) .
RESULTS
Microinjection of Virus-Producing Cells into Mid-Gestation Mouse Embryos. Fresh cell suspensions of the two cell lines q2-2-5 and C12C, which produce the replication-defective MSV-gpt and Mo-MuLV helper virus, respectively, were mixed in a ratio of 100:1. A total of 1-3 x 103 cells was microinjected into day 8.5 to 10.5 mid-gestation mouse embryos; 53% of the injected embryos (93/177) survived the physical trauma of microinjection to adulthood, one-half of which developed viremia (45/92), as shown by the presence of p30 in their serum 4 weeks after birth. These results show that microinjection of Mo-MuLV-producing cells into mid-gestation mouse embryos results in productive infection with the same efficiency as compared with microinjection of concentrated virus stocks as described (27 To analyze whether cells from infected mid-gestation embryos would continue to express MSV-gpt virus under in vitro conditions and could be selected directly for mycophenolic acid drug resistance, primary cultures from lung and the carcass of day 19 embryos were established (see Materials and Methods). Expression of MSV-gpt-defective virus could be detected after cocultivation of secondary cultures from embryos 2, 7, and 8 when cocultivated with NIH 3T3 cells, confirming the results shown in Table 1 . Furthermore, mycophenolic acid-resistant colonies could be selected directly from secondary carcass cell cultures of embryo 7 (see Table 1 ). To derive permanent cell lines, four drug-resistant clones were transformed with SV40, isolated, and grown into mass cultures.
Twenty-five adult animals derived from microinjected mid-gestation embryos and shown to be viremic by radioimmunoassay were analyzed for MSV-gpt virus expression at 2-4 months of age. Single cell suspensions were prepared from spleen, lung, and kidney, and infectious center assays were carried out as described above. As shown in (26) . When NIH 3T3 cultures were exposed to fresh blood samples of the experimental viremic animals, no mycophenolic acid-resistant colonies were observed, whereas a Mo-MuLV helper virus titer of 103 XC plaque-forming units per ml was found in the same blood samples.
To analyze whether infectious MSV-gpt virus can be rescued from drug-resistant NIH 3T3 clones after cocultivation with cells from different organs of infected animals, single colonies were isolated and grown into mass culture. The supernatant of these clones was titered for Mo-MuLV and MSV-gpt virus. Table 3 shows that all mycophenolic acidresistant NIH 3T3 clones produced both viruses at a titer that was comparable to the titer of the Cl2C and 4k2-2-5 cell lines, respectively, which were used to infect the mid-gestation embryos.
The results summarized in Tables 1, 2 , and 3 indicate that the recombinant MSV-gpt virus can be detected in different tissues of day 19 embryos or adults that have been exposed to virus-producing cells at the mid-gestation stage. The fraction of cells from infected embryos producing the recombinant Eco gpt virus was 3 to 5 orders of magnitude lower than the fraction of cells producing Mo-MuLV helper virus. DNA Analysis for gpt Sequences. To show the presence of MSV-gpt sequences in DNA from in vitro selected, mycophenolic acid-resistant clones (see above), high molecular weight DNA was prepared. The DNA was digested with Sst I, a restriction enzyme that cuts once in the 5' as well as the 3' long terminal repeat of the defective MSV-gpt genome, generating an internal fragment of 3.1 kilobases (kb). After separation on agarose gels and transfer to nitrocellulose filters, the DNA was probed with a 32P-labeled nick-translated pSV2-gpt DNA probe (6) . When DNA from four SV40-transformed clones derived directly from the carcass of embryo 7 (see above) was analyzed, a gpt-specific Sst I fragment -3.1 kb long was found (Fig. 1B, lanes b-e) . The pattern of Sst I fragments of higher (27) .
The fraction of cells producing the recombinant virus as detected by an infectious center assay was, however, [3] [4] [5] (37) . Furthermore, overproduction of the Eco gpt gene in cells of the developing embryo may be toxic, thus limiting the number of mycophenolic acid-resistant infectious centers in vitro. Apparent cell toxicity due to overproduction of XGPRT has been reported in tissue-culture experiments (38 
